Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008;22(6):497-518.
doi: 10.2165/00023210-200822060-00004.

Restless legs syndrome: pathophysiology, diagnosis and treatment

Affiliations
Review

Restless legs syndrome: pathophysiology, diagnosis and treatment

Pankaj Satija et al. CNS Drugs. 2008.

Abstract

Restless legs syndrome (RLS) is clinically defined by the presence of (i) an urge to move the legs with or without an actual paraesthesia; (ii) a worsening of symptoms with inactivity; (iii) improvement with activity; and (iv) a worsening of symptoms in the evening and at night. Patients may use a variety of semantic phrases to describe their symptoms but all must have an urge to move. Most people with RLS also have periodic limb movements during sleep, although this is not part of the clinical diagnostic criteria. RLS is very common. About 10% of all Caucasian populations have RLS, although it may be mild in the majority of cases. Women generally outnumber men by about 2:1. As a general rule, RLS severity worsens through the first seven to eight decades of life, but may actually lessen in old age. The aetiology of RLS is only partly understood. There is a strong genetic component, and several genetic linkages and three causative genes have been identified worldwide. Several medical conditions, including renal failure, systemic iron deficiency and pregnancy, and possibly neuropathy, essential tremor and some genetic ataxias, are also associated with high rates of RLS. In all cases to date, the actual CNS pathology of RLS demonstrates reduced iron stores, in a pattern that suggests that the homeostatic control of iron is altered, not just that there is not enough iron entering the brain. The relationship between reduced CNS iron levels and the clinical phenotype or treatment response to dopaminergics is not known but generates promising speculation. Treatment of RLS is usually rewarding. Most patients respond robustly to dopamine receptor agonists. Over time, response may lessen, or the patients may develop 'augmentation', whereby they have a worsening of symptoms, usually in the form of an earlier onset. Other treatment options include gabapentin, or similar antiepileptic drugs, and opioids. High-dose intravenous iron is a promising but still experimental approach.

PubMed Disclaimer

Similar articles

  • [Restless-legs syndrome].
    Karroum E, Konofal E, Arnulf I. Karroum E, et al. Rev Neurol (Paris). 2008 Aug-Sep;164(8-9):701-21. doi: 10.1016/j.neurol.2008.06.006. Epub 2008 Jul 24. Rev Neurol (Paris). 2008. PMID: 18656214 Review. French.
  • Restless Legs Syndrome: Contemporary Diagnosis and Treatment.
    Gossard TR, Trotti LM, Videnovic A, St Louis EK. Gossard TR, et al. Neurotherapeutics. 2021 Jan;18(1):140-155. doi: 10.1007/s13311-021-01019-4. Epub 2021 Apr 20. Neurotherapeutics. 2021. PMID: 33880737 Free PMC article. Review.
  • Restless legs syndrome: pathophysiology, clinical presentation and management.
    Trenkwalder C, Paulus W. Trenkwalder C, et al. Nat Rev Neurol. 2010 Jun;6(6):337-46. doi: 10.1038/nrneurol.2010.55. Nat Rev Neurol. 2010. PMID: 20531433 Review.
  • RLS patients: who are they?
    Schapira AH. Schapira AH. Eur J Neurol. 2006 Oct;13 Suppl 3:2-7. doi: 10.1111/j.1468-1331.2006.01585.x. Eur J Neurol. 2006. PMID: 16930376 Review.
  • Restless legs syndrome.
    Ekbom K, Ulfberg J. Ekbom K, et al. J Intern Med. 2009 Nov;266(5):419-31. doi: 10.1111/j.1365-2796.2009.02159.x. J Intern Med. 2009. PMID: 19817966 Review.

Cited by

References

    1. BMJ. 1996 May 25;312(7042):1339 - PubMed
    1. J Pineal Res. 2003 Nov;35(4):295-6 - PubMed
    1. Arch Intern Med. 2004 Jan 26;164(2):196-202 - PubMed
    1. Neurology. 2001 Nov 13;57(9):1717-9 - PubMed
    1. J Neurol. 1997 Apr;244(4 Suppl 1):S37-45 - PubMed

MeSH terms